Skip to main content

Table 1 Hemodynamic and INVOS data

From: Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction

  T1 T2 T3 T4 T5 T6 T7 T8 T9 T10
HR 60 62 64 64 61 64 65 66 63 68
Psyst 100 125 104 113 108 97 101 110 91 106
Pdiast 45 71 51 61 58 52 51 58 48 55
MAP 57 91 61 80 76 69 70 83 67 70
CVP 18 18 17 16 16 14 15 12 10 10
PAPsyst 56 48 46 46 44 44 40 39 31 35
PAPdiast 25 18 17 17 17 19 20 17 19 17
PAPmean 37 30 30 30 25 25 26 23 24 24
PAOP   18 17 16 16 16 16 16 16 15
CO 2.8 3.6 4.1 4.2 4.0 4.6 4.3 4.6 4.6 4.6
CI 1.6 2.1 2.4 2.4 2.0 2.7 2.5 2.7 2.7 2.7
SVR 1114 1622 858 1219 1200 956 1023 1234 991 1043
PVR   266 253 266 180 156 186 121 139 156
LVEF 25    40 40      
SvO2 49 70 80 80 82 82 80 60 65 58
INVOSLeft 45 59 59 55 60 60     
FiO2 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.4 0.4 0.21
Norepinephrine*   0.05 0.08 0.12 0.15 0.12 0.15 0.2 0.08 0.02
  1. * Dose in μg/kg/min
  2. HR in beats/minute
  3. Psyst, Pdiast, P mean, CVP, PAPsyst, PAPdiast, PAPmean, PCWP, all measured in mmHg
  4. CO = L/min, CI = L/m2/min SVO2 = %, INVOS = %
  5. T1 before levosimendan/norepinephrine infusion started
  6. T2 1 h after levosimendan infusion started
  7. T3, T4 2 and 3 hours after levosimendan infusion started
  8. T5 at end of surgery
  9. T6 T7 6 and 12 hours after surgery
  10. T8, T9, T10 18, 24, 36 hours after surgery